Successful Long-Term Treatment Combining Omalizumab and Anti-IL-5 Biologics in Allergic Bronchopulmonary Aspergillosis Daniel Laorden; Ester Zamarrón; Javier Domínguez-Ortega; David Romero; Santiago Quirce; Rodolfo Álvarez-Sala;